Hints and tips:
...This involves helping to identify stakeholders in the company’s investments, developing community engagement plans, and collecting data for reports....
...It currently ranks among the largest in that segment, alongside UBS and Bank of America Merrill Lynch....
...who foot the bill for America’s private health system....
...On Monday, it announced plans to buy Anacor Pharamaceuticals for an enterprise value of $5.2bn as it looks to add to its biopharmaceutical business....
...Cigna has also been at the forefront of trying to control costs with a so-called “wellness plan” and a “utilisation management” programme that aims to root out pointless medical tests and procedures....
...BD is best-known as a maker of needles and syringes and has an enterprise value of just over $20bn. It will pay 15 per cent of the price in BD shares....
...Inside, 14 competitively chosen teams, most with at least one MBA, are developing companies based on everything from social media websites to medical devices and software....
...Speaking to beyondbrics, Piramal explained the move as part of broader plan to rebalance the financials of his new group, as it moved upmarket and persevered with the expensive, uncertain and time-consuming...
...Amit Daryanani, analyst at RBC Capital Markets, said: “In addition, the company told analysts that it plans to continue growing its enterprise and solution portfolio, focusing more on margin expansion than...
...Washington’s postwar investment in technology and healthcare through military and medical research had enormously beneficial effects....
...It will operate independently from Abbott’s remaining “diversified medical products” business, which will continue to develop and sell medical devices, diagnostics, nutritional products and branded generic...
...Morgan Stanley advised the private equity consortium, with Bank of America Merrill Lynch and Credit Suisse also providing debt funding....
...The FTSE 100 stalwart announced on Thursday it would use the entire proceeds from the sale of Astra Tech, a Swedish dental implants and medical devices maker, for share buy-backs....
...Bain and Hellman & Friedman will pay 14.5 times the company’s earnings before interest, tax, depreciation and amortisation in the past year, reflecting Securitas’ fast profit growth plan and its non-cyclical...
...More recently, though, the company has made great play of its plans to raise its UK headcount as it hires more staff for its UK R&D and ancillary business services....
...The link with Humana will initially give it access to the insurer’s 4m private clients, before expanding to more than 17m covered through its specialist optical and dental plans as well as its work through...
...Separately the UK Medical Research Council, the government’s funding agency, maintains patents on developments by researchers in its own units and shares them with those it funds in universities....
...St Jude Medical , the medical device maker, rose 1.9 per cent to $41.73 after the company said it expected its fourth-quarter earnings figures to be at the top end of its previous estimates of between 72...
...acts as a consultant to biotechnology businesses and makers of medical devices....
...- N Rock chief’s resignation in pipeline - UK and France to sign formal defence treaty - Premium traffic behind BA’s flight to profit - BP and Halliburton face bigger claims -...
...Bank of America and Citigroup , both of which report second-quarter earnings on Friday, climbed 0.7 per cent higher to $15.21 and 1.7 per cent to $4.11 respectively....
...Bank of America fell 1.2 per cent to $15.24, JPMorgan Chase lost 2.3 per cent to $38.54 and Goldman Sachs dropped 2.2 per cent to $136.66....
...To understand Chinese business practice one has to move beyond the thinking of one single company, and examine how China Inc operates today....
...Already the CME and ICE exchanges have been preparing plans for a CDS market based on these principles....
...Wellcome Trust does for medical research....
International Edition